Delivery Order SPE2DR25D3012-SPE2DR26F4E7R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,413.13 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 100 micrograms (30-count supply). The contract is a firm fixed-price delivery order with no set-aside designation, awarded on January 8, 2026, with an ultimate completion date of January 9, 2026. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,333.76 delivery order to AmerisourceBergen Drug Corp for the supply of Levothyroxine 88 microgram capsules (30-count) on January 9, 2026, with completion targeted for January 12, 2026. This firm fixed-price, non-set-aside contract is to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order for levothyroxine sodium to AmerisourceBergen Drug Corp on December 22, 2025, with a ceiling value of $2,962.37 and an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Levothyroxine 150 MCG capsules (30-count units) with a ceiling value of $1,909.37. This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, is unclassified and carries no set-aside designation, indicating it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,887.81 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a thyroid hormone replacement medication. This firm fixed-price delivery order was issued on January 5, 2026, with an ultimate completion date of February 2, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's capability...
- The Defense Logistics Agency awarded a delivery order valued at $2,414.38 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication. The contract was competitively awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,018.63 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication commonly used in military and federal healthcare systems. The award, issued on January 9, 2026, with an ultimate completion date of February 6, 2026, represents a firm fixed-price contract with no set-aside designation, indicating open and competitive procurement. The products will be delivered to the company's...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone used to treat hypothyroidism and other thyroid conditions. This firm fixed price delivery order has a ceiling value of $1,801.64 and is scheduled for completion by October 20, 2025. The contract was awarded without a set-aside designation through competitive procurement, with performance taking place at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 microgram tablets of the drug levothyroxine. The contract has a ceiling value of $3,997.05 and runs through January 3, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E7RDelivery Order
On January 9, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,700.04 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 100 MCG vials. This firm fixed-price delivery order, which is not set aside for any specific business category, is scheduled for completion by January 12, 2026, with performance at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive IDC vehicle enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The contractor's federal contract portfolio demonstrates significant capability in fulfilling competitive pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/8/26 |